Mei Pharma Inc (MEIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2023 | 06-2022 | 06-2021 | 06-2020 | 06-2019 | |
| Sales | 48,816 | 40,697 | 34,796 | 27,756 | 4,915 |
| Cost of Goods | N/A | N/A | 1,408 | 2,671 | 4,263 |
| Gross Profit | 48,816 | 40,697 | 33,388 | 25,085 | 652 |
| Operating Expenses | 85,580 | 116,181 | 94,220 | 51,453 | 47,160 |
| Operating Income | -36,764 | -75,484 | -60,424 | -25,697 | -46,245 |
| Other Income | 4,926 | 21,030 | 19,118 | -21,475 | 29,427 |
| Pre-tax Income | -31,838 | -54,454 | -41,306 | -47,172 | -16,818 |
| Income Tax | N/A | N/A | 8 | 1 | 1 |
| Net Income Continuous | -31,838 | -54,454 | -41,314 | -47,173 | -16,819 |
| Net Income | $-31,838 | $-54,454 | $-41,314 | $-47,173 | $-16,819 |
| EPS Basic Total Ops | -4.78 | -8.75 | -7.40 | -10.40 | -4.80 |
| EPS Basic Continuous Ops | -4.78 | -8.75 | -7.34 | -10.36 | -4.73 |
| EPS Diluted Total Ops | -4.78 | -9.99 | -12.00 | -10.40 | -15.00 |
| EPS Diluted Continuous Ops | -4.78 | -8.70 | -7.22 | -10.36 | -4.65 |
| EPS Diluted Before Non-Recurring Items | -5.02 | -13.40 | -16.80 | -5.20 | -12.40 |
| EBITDA(a) | $-36,378 | $-75,158 | $-60,139 | $-25,361 | $-46,165 |